![Regina Fritsche-Danielson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Regina Fritsche-Danielson
Directeur Technique/Scientifique/R&D chez
ASTRAZENECA PLC
Profil
Regina Fritsche-Danielson is currently Director at SmartCella Holding AB and SVP, Head-Research & Early Development at AstraZeneca PLC since 2019.
Former positions include Director at Fluicell AB from 2022 to 2024 and Associate Professor at the University of Gothenburg.
Education includes a doctorate from the University of Gothenburg conferred in 1993.
Postes actifs de Regina Fritsche-Danielson
| Sociétés | Poste | Début |
|---|---|---|
| ASTRAZENECA PLC | Directeur Technique/Scientifique/R&D | 01/01/2019 |
SmartCella Holding AB
 SmartCella Holding AB BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapy and delivery devices for cardiac diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Regina Fritsche-Danielson
| Sociétés | Poste | Fin |
|---|---|---|
| FLUICELL AB | Directeur/Membre du Conseil | 28/08/2024 |
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Regina Fritsche-Danielson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluicell AB
 Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research | Health Technology |
SmartCella Holding AB
SmartCella Holding AB BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapy and delivery devices for cardiac diseases | Health Technology |
Choisissez Zonebourse 
